Financial

ARTIMPLANT INTERIM REPORT JANUARY – SEPTEMBER 2009

· Net revenue for the third quarter increased to SEK 5.5 million (2.3) and for January-September to SEK 18.2 million (7.5)*

· The net loss for the third quarter totaled SEK 4.7 million (4.3) and for January-September SEK 13.2 million (16.6)

· Earnings per share for the third quarter amounted to SEK -0.08 (-0.07) and for January-September SEK -0.22 (-0.28)

· Sales of Artelon® Spacer for the third quarter increased to SEK 2.5 million (1.2) and for January-September to SEK 10.7 million (4.9)

· Sales of Artelon® Tissue Reinforcement for the third quarter increased to SEK 2.5 million (1.1) and for January-September to SEK 6.9 million (2.5)

· Emerging Medical Group was appointed as the new sales management team for Artimplant USA

N.B. This is a translation from Swedish. The Swedish version shall always take precedence.

Tags

Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close
Themed By teapots